645 Shares in The Clorox Company (NYSE:CLX) Purchased by CoreFirst Bank & Trust

CoreFirst Bank & Trust bought a new stake in The Clorox Company (NYSE:CLXFree Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor bought 645 shares of the company’s stock, valued at approximately $105,000.

Several other hedge funds also recently bought and sold shares of CLX. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares in the last quarter. Continuum Advisory LLC increased its stake in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Millstone Evans Group LLC purchased a new stake in Clorox during the fourth quarter worth about $31,000. Asset Planning Inc acquired a new stake in shares of Clorox during the fourth quarter worth about $32,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new position in shares of Clorox in the fourth quarter valued at approximately $36,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CLX. Barclays increased their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. JPMorgan Chase & Co. boosted their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Evercore ISI increased their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, DA Davidson lowered their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $159.62.

Check Out Our Latest Report on Clorox

Clorox Stock Performance

Shares of CLX opened at $141.80 on Wednesday. The company has a market capitalization of $17.47 billion, a price-to-earnings ratio of 38.74, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The stock has a 50 day moving average price of $152.23 and a 200 day moving average price of $159.43.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the business posted $2.16 EPS. Research analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.44%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s payout ratio is currently 133.33%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.